Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
about
Adoptive T-Cell ImmunotherapyCD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsPreventing stem cell transplantation-associated viral infections using T-cell therapyCord blood graft engineeringT-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effectRespiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsT lymphocytes targeting native receptorsT-cell therapies for HIVNovel immunotherapies for hematologic malignanciesAdoptive T-cell therapy for LeukemiaCellular immunotherapy for pediatric solid tumorsCurrent translational and clinical practices in hematopoietic cell and gene therapyAntiviral T-cell therapyTherapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cellsRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferNovel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccineAdoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytesVirus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaIn vivo imaging of T cell delivery to tumors after adoptive transfer therapy.Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.T-cell-based therapies for malignancy and infection in childhood.Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationGene and cell therapy for children--new medicines, new challenges?Controlling cytomegalovirus: helping the immune system take the leadComparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.Immunotherapy: opportunities, risks and future perspectivesAdverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersGlobal transcriptional analysis for biomarker discovery and validation in cellular therapies.Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesImmunotherapy of human cancers using gene modified T lymphocytes.
P2860
Q26782845-5690A537-7CB6-43E0-81C8-EF3594028DA8Q26783433-9FFFAB5F-2A46-4029-8167-238620201D8FQ26795540-8EAED92E-5D5E-42B0-9160-84FDEB7E9A9EQ26801365-5BC836A2-7FAC-4AA6-BAE5-5103550B04E9Q26822376-BAC9D8F7-C812-4CA8-9323-602A050E3376Q26826830-F7BA5AF0-BE05-4764-902A-9D408C0D797BQ26829188-6870653F-2833-49C6-8F9E-063A2B61C337Q26853345-4045671B-827E-4704-B208-60506B66E549Q26866079-1708F604-FC34-42EA-955A-75D2F3EF8F60Q27004436-7685DF9C-23FF-49B7-811C-C749EF994DA8Q27006934-9A2991E8-7288-4840-A9E4-6A674D210932Q27014912-DB855283-AC56-40DD-A065-6AAD779D8315Q27024456-DC0F1F39-4A8B-4461-9735-29B28CF8EB8BQ27028006-4D8891AD-0A2F-4F50-9EEA-3ABDB13ED7B8Q27308832-4F680990-BBAD-47B7-8DB1-DC550F239225Q28079823-B5046066-2EBB-41CA-89AA-B727D1CDC8AAQ28727481-76E613BF-5289-4FEE-BFA3-D64B1E3B5DBDQ28749468-23F121E3-3BC4-4145-9835-ED77126177C6Q29393780-EA36AF6C-2CC6-464E-AA51-4C8C75E0C5EBQ29622835-BB733044-0CAA-44FC-A26A-33B50CFA9AF4Q30479855-C77C6C5C-F8C6-4BCC-A545-6FEEFD3E6BD4Q33303005-6B99117B-E8C2-4513-939D-3578A916D56BQ33634455-3E82C17F-360F-41B4-9AA0-0E201C6C2EC0Q33713932-05705F18-BC5A-4A22-A7BA-FCC91BB6A5E4Q33724261-2C1C5192-F724-4D87-9A5F-446D641AA4A0Q33726613-1E268853-6F21-4D8D-A897-9DE7F5E71C10Q33734872-E05A5FB2-A18C-4139-9E97-0132BD35B515Q33750862-7AA121C0-68B4-4E5A-9D23-E43D1E81FF68Q33780277-FF2BF468-3101-4EFD-8E92-D4109D838CD5Q33819841-9AA4B754-FA79-45B3-B5DD-1491219036B5Q33820695-253330B8-045A-41F2-B0D9-533754F31B80Q33921073-F7C3C6FA-169A-4A1D-9EFA-74E5DB9231D7Q33941012-FD9B20AA-F93F-4F1C-9991-007E1D258ECAQ34039992-912FEE20-8683-4079-82DD-B370FF924F3DQ34122292-C52752E8-FCC1-476A-A1C6-ADABE507FC67Q34163218-5EFDBD6A-018F-4800-8C5C-E9196BCE4EADQ34166602-615D67FB-2487-42AE-A005-E8324A66EA80Q34171422-A3DB971D-CD36-475C-A777-53A7F4579DA5Q34186486-1EE6F406-BE18-4453-8B82-05C6716E4D00Q34188383-6BE17106-6769-4168-BFBB-094613CF7101
P2860
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@en
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@nl
type
label
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@en
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@nl
prefLabel
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@en
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@nl
P2093
P2860
P356
P1433
P1476
Monoculture-derived T lymphocy ...... immunocompromised individuals.
@en
P2093
Adrian P Gee
Ann M Leen
Catherine M Bollard
Chung-Che Chang
Cliona M Rooney
G Doug Myers
George Carrum
Heidi Weiss
Helen E Heslop
Jeffrey J Molldrem
P2860
P2888
P304
P356
10.1038/NM1475
P407
P577
2006-09-24T00:00:00Z
P5875
P6179
1005922468